Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongrong Yu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Genetics|January 2, 2026
Case Report: UMOD gene mutation and phenotypic overlap with REN in autosomal dominant tubulointerstitial kidney diseaseJingying Xu, Enhui Chen, Wen Shi, et al.
Renal Failure|June 24, 2026
Clinical characteristics and prognosis of peritoneal dialysis-associated peritonitis caused by non-fermenting Gram-negative bacteria: a single-center retrospective analysisHuiling Yan, Wenhui He, Dongrong Yu, et al.
BMC Nephrology|November 29, 2024
Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective studyLi Gao, Xuan Zhang, Dongrong Yu, et al.
European Journal of Medical Research|July 9, 2021
Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family historyYin Ding, Xuanli Tang, Yuanyuan Du, et al.
Drug Design, Development and Therapy|February 26, 2020
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 SignalingJin Yu, Caifeng Zhu, Jiazhen Yin, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 20, 2024
Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic NephropathyYinfeng Chen, Xiaying Wang, Jie Min, et al.
BMC Nephrology|March 6, 2022
Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot studyHongmei Zhang, Bin Zhu, Liyang Chang, et al.
Frontiers in Endocrinology|March 24, 2025
Clinical characteristics and prognostic analysis of patients with type 2 diabetic kidney disease and non-diabetic kidney diseaseCan Yu, Wen Shi, Enhui Chen, et al.
International Immunopharmacology|October 8, 2024
Identification and validation of diagnostic markers related to immunogenic cell death and infiltration of immune cells in diabetic nephropathyDe Jin, Xiao Tu, Wanyue Xu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Genetics|January 2, 2026
Case Report: UMOD gene mutation and phenotypic overlap with REN in autosomal dominant tubulointerstitial kidney diseaseJingying Xu, Enhui Chen, Wen Shi, et al.
Renal Failure|June 24, 2026
Clinical characteristics and prognosis of peritoneal dialysis-associated peritonitis caused by non-fermenting Gram-negative bacteria: a single-center retrospective analysisHuiling Yan, Wenhui He, Dongrong Yu, et al.
BMC Nephrology|November 29, 2024
Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective studyLi Gao, Xuan Zhang, Dongrong Yu, et al.
European Journal of Medical Research|July 9, 2021
Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family historyYin Ding, Xuanli Tang, Yuanyuan Du, et al.
Drug Design, Development and Therapy|February 26, 2020
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 SignalingJin Yu, Caifeng Zhu, Jiazhen Yin, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 20, 2024
Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic NephropathyYinfeng Chen, Xiaying Wang, Jie Min, et al.
BMC Nephrology|March 6, 2022
Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot studyHongmei Zhang, Bin Zhu, Liyang Chang, et al.
Frontiers in Endocrinology|March 24, 2025
Clinical characteristics and prognostic analysis of patients with type 2 diabetic kidney disease and non-diabetic kidney diseaseCan Yu, Wen Shi, Enhui Chen, et al.
International Immunopharmacology|October 8, 2024
Identification and validation of diagnostic markers related to immunogenic cell death and infiltration of immune cells in diabetic nephropathyDe Jin, Xiao Tu, Wanyue Xu, et al.
Pageof 2